PUBLICACIÓN
Dihydrofolate reductase genetic polymorphisms affect methotrexate dose requirements in pediatric patients with acute lymphoblastic leukemia on maintenance therapy
Gervasini G; de Murillo SG; Jiménez M; de la Maya MD; Vagace JM
2017 Journal of Pediatric Hematology/Oncology
Hematology (Q3), Oncology (Q3), Pediatrics, Perinatology and Child Health (Q2)
JCR: 1.06
SJR: 0.459
CITAS
10
DOI
10.1097/mph.0000000000000908
EID
2-s2.0-85024502614
ISSN
1077-4114
EISSN
1536-3678
BIBTEX
@article{PMID:28719513, title = {Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy.}, author = {Gervasini G and de Murillo SG and Jiménez M and de la Maya MD and Vagace JM}, doi = {10.1097/mph.0000000000000908}, journal = {Journal of pediatric hematology/oncology}, month = {11}, year = {2017} }
AUTORES DE LA UEX
